Cargando…
From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientif...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584537/ https://www.ncbi.nlm.nih.gov/pubmed/34769461 http://dx.doi.org/10.3390/ijms222112031 |
_version_ | 1784597473290878976 |
---|---|
author | Cortes-Figueiredo, Filipe Carvalho, Filipa S. Fonseca, Ana Catarina Paul, Friedemann Ferro, José M. Schönherr, Sebastian Weissensteiner, Hansi Morais, Vanessa A. |
author_facet | Cortes-Figueiredo, Filipe Carvalho, Filipa S. Fonseca, Ana Catarina Paul, Friedemann Ferro, José M. Schönherr, Sebastian Weissensteiner, Hansi Morais, Vanessa A. |
author_sort | Cortes-Figueiredo, Filipe |
collection | PubMed |
description | Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientific, USA) is an innovative library preparation kit suitable for degraded samples and low DNA input. However, its bioinformatic processing occurs in the enterprise Ion Torrent Suite™ Software (TSS), yielding BAM files aligned to an unorthodox version of the revised Cambridge Reference Sequence (rCRS), with a heteroplasmy threshold level of 10%. Here, we present an alternative customizable pipeline, the PrecisionCallerPipeline (PCP), for processing samples with the correct rCRS output after Ion Torrent sequencing with the Precision ID library kit. Using 18 samples (3 original samples and 15 mixtures) derived from the 1000 Genomes Project, we achieved overall improved performance metrics in comparison with the proprietary TSS, with optimal performance at a 2.5% heteroplasmy threshold. We further validated our findings with 50 samples from an ongoing independent cohort of stroke patients, with PCP finding 98.31% of TSS’s variants (TSS found 57.92% of PCP’s variants), with a significant correlation between the variant levels of variants found with both pipelines. |
format | Online Article Text |
id | pubmed-8584537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85845372021-11-12 From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel Cortes-Figueiredo, Filipe Carvalho, Filipa S. Fonseca, Ana Catarina Paul, Friedemann Ferro, José M. Schönherr, Sebastian Weissensteiner, Hansi Morais, Vanessa A. Int J Mol Sci Article Despite a multitude of methods for the sample preparation, sequencing, and data analysis of mitochondrial DNA (mtDNA), the demand for innovation remains, particularly in comparison with nuclear DNA (nDNA) research. The Applied Biosystems™ Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientific, USA) is an innovative library preparation kit suitable for degraded samples and low DNA input. However, its bioinformatic processing occurs in the enterprise Ion Torrent Suite™ Software (TSS), yielding BAM files aligned to an unorthodox version of the revised Cambridge Reference Sequence (rCRS), with a heteroplasmy threshold level of 10%. Here, we present an alternative customizable pipeline, the PrecisionCallerPipeline (PCP), for processing samples with the correct rCRS output after Ion Torrent sequencing with the Precision ID library kit. Using 18 samples (3 original samples and 15 mixtures) derived from the 1000 Genomes Project, we achieved overall improved performance metrics in comparison with the proprietary TSS, with optimal performance at a 2.5% heteroplasmy threshold. We further validated our findings with 50 samples from an ongoing independent cohort of stroke patients, with PCP finding 98.31% of TSS’s variants (TSS found 57.92% of PCP’s variants), with a significant correlation between the variant levels of variants found with both pipelines. MDPI 2021-11-06 /pmc/articles/PMC8584537/ /pubmed/34769461 http://dx.doi.org/10.3390/ijms222112031 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cortes-Figueiredo, Filipe Carvalho, Filipa S. Fonseca, Ana Catarina Paul, Friedemann Ferro, José M. Schönherr, Sebastian Weissensteiner, Hansi Morais, Vanessa A. From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title | From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title_full | From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title_fullStr | From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title_full_unstemmed | From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title_short | From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel |
title_sort | from forensics to clinical research: expanding the variant calling pipeline for the precision id mtdna whole genome panel |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584537/ https://www.ncbi.nlm.nih.gov/pubmed/34769461 http://dx.doi.org/10.3390/ijms222112031 |
work_keys_str_mv | AT cortesfigueiredofilipe fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT carvalhofilipas fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT fonsecaanacatarina fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT paulfriedemann fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT ferrojosem fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT schonherrsebastian fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT weissensteinerhansi fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel AT moraisvanessaa fromforensicstoclinicalresearchexpandingthevariantcallingpipelinefortheprecisionidmtdnawholegenomepanel |